Bio Green Med Solution (bgms 6 Perp)Preferred / convertible
13F holders, Q2 2025 (June 30)1holders −3
0new positions
4sold out
$5.49avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Bio Green Med Solution (bgms 6 Perp) in their 13F filings, down 3 from Q1 2025. 0 opened new positions and 4 sold out. The largest holder was VSM Wealth Advisory, LLC ($26K).
- Company
- Bio Green Med Solution (bgms 6 Perp)
- Filed as
- CYCLACEL PHARMACE 6pcnt PFDCONV (Q2 2025)
- CUSIP
- 23254L207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 4 | $84K |
All 13F filers, Q1 2025 → Q2 2025: 2,025 shares bought and 17,643 shares sold, net −15,618 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| VSM Wealth Advisory, LLC | — | Add +72.9% | 4,802 | $26K |
"% of holder's portfolio" is BIO GREEN MED SOLUTION (BGMS 6 PERP)'s weight in each manager's 13F, not the share of Bio Green Med Solution (bgms 6 Perp) the manager owns.